ARCHIVES

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

This article is from The Cancer Letter archive.

Vol. 34 No. 42 | November 14, 2008

Download PDF Visit The Full Archive

Related Articles

RFP To Be Issued For Two More Neutron Therapy Facilities; Winners To Conduct Clinical Trials

October 27, 1978

In Brief: Pass Joins Karmanos Cancer Institute; Nag President-Elect, Brachytherapy Society

June 27, 1997

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

Fibrolast Interferon Contract Signed

May 2, 1980

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

Exit Joseph Nevins: Duke’s Genomics Luminary Quietly Leaves

October 18, 2013